BioLife Solutions, Inc.
BioLife Solutions, Inc. (BLFS) Revenue
Annual & quarterly revenue history · segment & region breakdown
BLFS · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBioLife Solutions, Inc. trailing twelve-month (TTM) revenue is $0.10B, an increase of 16.97% year-over-year from $0.10B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.10B | +$0.01B | +16.97% |
| 2024-12-31 | $0.08B | +$0.01B | +8.44% |
| 2023-12-31 | $0.08B | -$0.00B | -0.50% |
| 2022-12-31 | $0.08B | -$0.04B | -36.02% |
| 2021-12-31 | $0.12B | +$0.07B | +147.79% |
| 2020-12-31 | $0.05B | +$0.02B | +75.69% |
| 2019-12-31 | $0.03B | +$0.01B | +38.64% |
| 2018-12-31 | $0.02B | +$0.01B | +79.11% |
| 2017-12-31 | $0.01B | +$0.00B | +33.97% |
| 2016-12-31 | $0.01B | +$0.00B | +27.57% |
Compare revenue vs peers
Medical - Instruments & SuppliesCompare BLFS revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income BioLife Solutions, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
BioLife Solutions, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from BioLife Solutions, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BLFS revenue · 4 questionsBLFS's trailing twelve-month (TTM) revenue is $0.10B. That is an increase of 16.97% year-over-year from $0.10B in FY2025.
▸ Source: FMP · BioLife Solutions, Inc. SEC filings · GAAP · BioLife Solutions, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026